Skip to main content

Day: December 16, 2024

Helium Evolution Provides Encouraging Preliminary Update on 10-1 Well

CALGARY, Alberta, Dec. 16, 2024 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, is pleased to announce preliminary test results from its 10-1-4-9W3 helium discovery well (the “10-1 Well”) along the Mankota helium fairway. HEVI holds a 20% working interest in the 10-1 Well, in partnership with the operator, North American Helium Inc. (“NAH”). Completion, perforation and initial production testing of the 10-1 Well is ongoing. At the end of a 4-day extended flow testing period, the 10-1 Well was producing approximately 9.5 million standard cubic feet per day (“MMscf/d”) at 10,800 kilopascal (“kPa”) flowing tubing pressure. The preliminary test also confirmed a helium content...

Continue reading

Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers

Cibus’ Rice Herbicide Tolerance (HT-3) Commercialization Efforts Continue Promising Progress to deliver a new Weed Management Solution for Farmers in the U.S. Cibus and its partners Albaugh and RTDC Continue Their Research and Development Collaboration to Enable Commercialization of Cibus’ Clethodim-Tolerant HT-3 Rice Trait SAN DIEGO, Dec. 16, 2024 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties announced an agreement affirming its collaboration with RTDC Corporation Limited and Albaugh LLC to provide Clethodim as part of Cibus’ weed management solution for U.S. rice farmers using Cibus’ HT-3 trait. This continued collaboration with Albaugh, a global leader in crop protection, lends complementary market development...

Continue reading

Barnwell Industries, Inc. Reports Results for its Fourth Quarter and Year Ended September 30, 2024

Success of Twining Drilling Program Continues While OptimizationProjects Maintain Production Levels and Reduce Operating Costs HONOLULU, Dec. 16, 2024 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) today reported financial results for its fourth quarter and year ended September 30, 2024. The Company had revenue of $4,268,000 and a net loss of $1,883,000 or $0.19 per share for the fourth quarter and had revenue of $21,724,000 and a net loss of $5,565,000 or $0.56 per share for the full year. The Company remains debt free and ended the fiscal year with $4,505,000 in cash and cash equivalents and $1,071,000 in working capital. Continuing Optimization Program is Showing Positive Results For the year ended September 30, 2024, production of natural gas and natural gas liquids increased by 6% and 23%, respectively,...

Continue reading

Form 8.5 (EPT/RI) m- Warpaint London Plc

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Warpaint London Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Warpaint London Plc(d)        Date dealing undertaken: 13 December 2024(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? Yes – Brand Architekts Group plc2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases...

Continue reading

Parsons Successfully Conducts First-Of-A-Kind Threat Environment Demonstration

Milestone Event Combines Autonomous Systems and Threat Emulation Capabilities CHANTILLY, Va., Dec. 16, 2024 (GLOBE NEWSWIRE) — In a groundbreaking initiative to enhance U.S. Air Force training operations, Parsons Corporation (NYSE: PSN), in collaboration with the University of Southern Mississippi, the Mississippi Air National Guard, and SeaTrac Systems, has integrated the company’s Threat Representative Environment (TReX) emulator onto a remotely operated SeaTrac Unmanned Surface Vehicle (USV) during maritime operations. This first-of-its-kind demonstration was conducted off the U.S. Gulf of Mexico in November and establishes a new benchmark for realistic training environments for Air Force pilots and operators. Parsons’ TReX threat emulator is designed to simulate threats that military personnel may encounter during real-world...

Continue reading

Kering: Monthly statement on the total number of shares and voting rights (December 2024)

Kering – Statement Number of Shares and voting rights – 13.12.2024 KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS December 16, 2024 Monthly statement on the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers)DateTotal number ofsharesTotal number of voting rightstheoretical 1 exercisable 2December 13, 2024 123,420,778 176,707,318 175,888,2331 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223-11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights.AttachmentKering – Statement...

Continue reading

MannKind Announces Six-Month Results From Phase 3 INHALE-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)

Company plans to meet with FDA regarding potential sNDA submission in 1H 2025 Call planned today at 8:30 a.m. (ET) to discuss company’s diabetes program progressionDANBURY, Conn. and WESTLAKE VILLAGE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases, today announced six-month results from its Phase 3 INHALE-1 study of Afrezza (insulin human) Inhalation Powder in children and adolescents (aged 4-17 years of age). MannKind expects to submit a request for a supplemental new drug application (sNDA) meeting with the U.S. Food and Drug Administration (FDA) in 1H 2025 to discuss the data and filing timeline. The INHALE-1 study is a 26-week, open-label...

Continue reading

Kaldvik AS: Approval of loan covenant waiver

Reykjavik, 16 December 2024:  Kaldvik AS has initiated a waiver process with its lenders regarding the financial covenants in its senior bank debt facility of EUR 179.9 million. This process has now been successfully concluded. The lenders have granted a waiver of the following covenants for Q4 2024:The interest cover shall at all times be equal to or more than 3.0x; Leverage shall not exceed 5.0x in Q4 2024; and The liquidity is maintained at minimum EUR 10,000,000.For further information, please contact:Contacts: Róbert Róbertsson, CFO of Kaldvik AS: +354 843 0086 (mobile) About Kaldvik ASKaldvik AS is one of the leading salmon farmers in Iceland. Kaldvik AS has a well-developed and fully integrated value-chain controlling all steps from hatchery to sales, enabling the group to provide its customer with a sustainable premium product....

Continue reading

Nokia and EOLO deploy Europe’s first 5G standalone mmWave network in Italy

Press Release Nokia and EOLO deploy Europe’s first 5G standalone mmWave network in Italy  Nokia to deploy the first 5G standalone mmWave network in Europe delivering enhanced customer experience with premium capacity and coverage. New network infrastructure to support EOLO’s ambitions to connect underserved communities in Italy. Nokia’s Shikra mmWave radios and FastMile FWA receivers to support Fixed Wireless Access services.16 December 2024 Espoo, Finland – Nokia announced it has signed a four-year deal with EOLO, a Benefit Corporation, and the first B Corp in the Italian telecommunications sector, leader in FWA (fixed wireless access) connectivity, to deploy the first 5G standalone mmWave Radio Access Network in Europe. The deal supports EOLO’s ambitions to connect underserved communities, helping to bridge the digital divide...

Continue reading

Offentliggørelse af prospekt, Investeringsforeningen Wealth Invest

I forlængelse af foreningens fondsbørsmeddelelse den 24. september 2024, offentliggøres et opdateret prospekt for en række afdelinger i Investeringsforeningen Wealth Invest. Prospektet er blevet opdateret som følge af fusionen mellem CT EM Aktier og Metropolis Globale Aktier, som er gennemført dags dato, med sidstnævnte som fortsættende afdeling. Prospektet er vedhæftet denne meddelelse og kan ligeledes tilgås via foreningens hjemmeside. For eventuelle spørgsmål kontakt Lise Bøgelund Jensen, direktør i foreningens investeringsforvaltningsselskab, på telefon 33 28 28 28.Med venlig hilsen Investeringsforeningen Wealth InvestAttachment2024 12 16 Prospekt WI Secure Spectrum

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.